As previously noted for its osteogenic effects, Luciani et al
Embracing GLP-1 therapy represents a proactive step toward better health for perimenopausal women
Most practitioners start tirzepatide at its lowest dose of 2.5 mg regardless of the previous semaglutide dose to minimize gastrointestinal side effects during the transition
Given the increased appreciation of the reciprocal nature of dyslipidemia, obesity, dysglycemia and liver disease, including nonalcoholic fatty liver disease (NAFLD) and traditional risk factors, a new classification of metabolic (dysfunction) associated fatty liver disease (MAFLD) has emerged (3)
Additionally, glycine inhibits proteolytic gene expression, which is a technical way of saying it reduces the signals that tell your body to break down muscle proteins for energy
So, what's the tea on microdosing